Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives

A boom in respiratory tract infection cases has inflicted a socio-economic burden on the healthcare system worldwide, especially in developing countries. Limited alternative therapeutic options have posed a major threat to human health. Nanotechnology has brought an immense breakthrough in the pharm...

Full description

Bibliographic Details
Main Authors: Minhua Chen, Zhangxuan Shou, Xue Jin, Yingjun Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Drug Delivery
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/10717544.2022.2089294
_version_ 1818002425746817024
author Minhua Chen
Zhangxuan Shou
Xue Jin
Yingjun Chen
author_facet Minhua Chen
Zhangxuan Shou
Xue Jin
Yingjun Chen
author_sort Minhua Chen
collection DOAJ
description A boom in respiratory tract infection cases has inflicted a socio-economic burden on the healthcare system worldwide, especially in developing countries. Limited alternative therapeutic options have posed a major threat to human health. Nanotechnology has brought an immense breakthrough in the pharmaceutical industry in a jiffy. The vast applications of nanotechnology ranging from early diagnosis to treatment strategies are employed for respiratory tract infections. The research avenues explored a multitude of nanosystems for effective drug delivery to the target site and combating the issues laid through multidrug resistance and protective niches of the bacteria. In this review a brief introduction to respiratory diseases and multifaceted barriers imposed by bacterial infections are enlightened. The manuscript reviewed different nanosystems, i.e. liposomes, solid lipid nanoparticles, polymeric nanoparticles, dendrimers, nanogels, and metallic (gold and silver) which enhanced bactericidal effects, prevented biofilm formation, improved mucus penetration, and site-specific delivery. Moreover, most of the nanotechnology-based recent research is in a preclinical and clinical experimental stage and safety assessment is still challenging.
first_indexed 2024-04-14T03:45:45Z
format Article
id doaj.art-109105aaad2c4f6ba5407176d1feb1f1
institution Directory Open Access Journal
issn 1071-7544
1521-0464
language English
last_indexed 2024-04-14T03:45:45Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Drug Delivery
spelling doaj.art-109105aaad2c4f6ba5407176d1feb1f12022-12-22T02:14:15ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642022-12-012912442245810.1080/10717544.2022.2089294Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectivesMinhua Chen0Zhangxuan Shou1Xue Jin2Yingjun Chen3Emergency & Intensive Care Unit Center, Department of Intensive Care Unit, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, ChinaDepartment of Pharmacy, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaCenter for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, ChinaDepartment of Infectious Diseases, People’s Hospital of Tiantai County, Taizhou, ChinaA boom in respiratory tract infection cases has inflicted a socio-economic burden on the healthcare system worldwide, especially in developing countries. Limited alternative therapeutic options have posed a major threat to human health. Nanotechnology has brought an immense breakthrough in the pharmaceutical industry in a jiffy. The vast applications of nanotechnology ranging from early diagnosis to treatment strategies are employed for respiratory tract infections. The research avenues explored a multitude of nanosystems for effective drug delivery to the target site and combating the issues laid through multidrug resistance and protective niches of the bacteria. In this review a brief introduction to respiratory diseases and multifaceted barriers imposed by bacterial infections are enlightened. The manuscript reviewed different nanosystems, i.e. liposomes, solid lipid nanoparticles, polymeric nanoparticles, dendrimers, nanogels, and metallic (gold and silver) which enhanced bactericidal effects, prevented biofilm formation, improved mucus penetration, and site-specific delivery. Moreover, most of the nanotechnology-based recent research is in a preclinical and clinical experimental stage and safety assessment is still challenging.https://www.tandfonline.com/doi/10.1080/10717544.2022.2089294Respiratory tract infectionsbacterial infectionssmart nanosystemsnanodiagnostics
spellingShingle Minhua Chen
Zhangxuan Shou
Xue Jin
Yingjun Chen
Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives
Drug Delivery
Respiratory tract infections
bacterial infections
smart nanosystems
nanodiagnostics
title Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives
title_full Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives
title_fullStr Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives
title_full_unstemmed Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives
title_short Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives
title_sort emerging strategies in nanotechnology to treat respiratory tract infections realizing current trends for future clinical perspectives
topic Respiratory tract infections
bacterial infections
smart nanosystems
nanodiagnostics
url https://www.tandfonline.com/doi/10.1080/10717544.2022.2089294
work_keys_str_mv AT minhuachen emergingstrategiesinnanotechnologytotreatrespiratorytractinfectionsrealizingcurrenttrendsforfutureclinicalperspectives
AT zhangxuanshou emergingstrategiesinnanotechnologytotreatrespiratorytractinfectionsrealizingcurrenttrendsforfutureclinicalperspectives
AT xuejin emergingstrategiesinnanotechnologytotreatrespiratorytractinfectionsrealizingcurrenttrendsforfutureclinicalperspectives
AT yingjunchen emergingstrategiesinnanotechnologytotreatrespiratorytractinfectionsrealizingcurrenttrendsforfutureclinicalperspectives